Cancer BiologybioRxivPreprint
Targeting glucocorticoid-induced CD20 activation in preclinical models of B-ALL
Jérémy Bigot, Mathieu Bouttier, Vincent Fregona…·Bastien Gerby
This study identifies CD20 as an actionable target in B-ALL MRD using PDX models and single-cell RNA sequencing, showing anti-CD20 antibodies can eradicate drug-resistant cells.